$16.740
+3.169 (+18.93%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
JSPR Prediction & Forecast by Similar Chart Analysis
Alphio's JSPR stock price prediction model matches the current Jasper Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.76 (+0.11%). The 1-week path is $17.13 (+2.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Jasper Therapeutics Inc Stock?
Jasper Therapeutics Inc is a good buy right now, primarily due to its recent price increase of 18.93% yesterday and a significant reduction in net loss to $2.76 million in Q2 2026 from $26.72 million the previous year. The company is also advancing its clinical pipeline, with an end-of-Phase 2 meeting for KP-104 expected in the first half of 2027, which could drive future growth. However, the main risk is the current negative earnings per share (EPS) of -0.10 and the need for additional funding to support its clinical studies.
JSPR stock price ended at $16.74 on Friday, after rising +18.93%
Jasper Therapeutics Inc (JSPR) last closed at $16.7399998, gaining +18.93%. These facts feed the 1-day and 1-week JSPR price prediction above.
Forecast Drivers
Jasper Therapeutics Inc (JSPR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches JSPR, ranked by similarity.
Seasonality analysis for JSPR
Historically the probability of a positive November return for JSPR is 45.45%. December offers the highest probability of a positive month at 48.84%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for JSPR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $4.01 | $4.02 | $4.57 | -75.98% |
| Dec 2026 | $3.51 | $3.71 | $3.91 | -77.83% |
In 2026, Jasper Therapeutics Inc (JSPR) is projected to range from $3.51 to $4.57.
Jasper Therapeutics Inc 2026 monthly forecast
In Nov 2026, Jasper Therapeutics Inc is projected to average $4.02, with a low of $4.01 and high of $4.57.
In Dec 2026, Jasper Therapeutics Inc is projected to average $3.71, with a low of $3.51 and high of $3.91.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.